Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials.

Derosa G, Maffioli P, Cicero AF.

Expert Opin Biol Ther. 2012 Aug;12(8):1113-24. doi: 10.1517/14712598.2012.704014. Review.

PMID:
22780092
2.

Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies.

Pirillo A, Catapano AL.

Atherosclerosis. 2015 Dec;243(2):449-61. doi: 10.1016/j.atherosclerosis.2015.09.032. Epub 2015 Sep 30. Review.

PMID:
26520899
3.

Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.

Goldberg RB, Fonseca VA, Truitt KE, Jones MR.

Arch Intern Med. 2008 Jul 28;168(14):1531-40. doi: 10.1001/archinte.168.14.1531.

PMID:
18663165
4.

The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus.

Huang ES, Meigs JB, Singer DE.

Am J Med. 2001 Dec 1;111(8):633-42.

PMID:
11755507
5.

Management of cardiovascular risk factors with pioglitazone combination therapies in type 2 diabetes: an observational cohort study.

Rodríguez A, Reviriego J, Karamanos V, del Cañizo FJ, Vlachogiannis N, Drossinos V; ECLA Study Group..

Cardiovasc Diabetol. 2011 Feb 11;10:18. doi: 10.1186/1475-2840-10-18.

6.

A primary care register for impaired glucose handling (IGH): impact on cardiometabolic profile.

Heald AH, Knapman H, Nair S, Chambers T, Radford D, Rushton T, Anderson SG.

Prim Care Diabetes. 2012 Oct;6(3):213-9. doi: 10.1016/j.pcd.2012.02.002. Epub 2012 May 4.

PMID:
22560663
7.

Glucose lowering and cardiovascular disease: what do we know and what should we do?

Cheng AY, Leiter LA.

Eur J Cardiovasc Prev Rehabil. 2010 May;17 Suppl 1:S25-31. doi: 10.1097/01.hjr.0000368194.32356.5f. Review.

PMID:
20489417
8.

Glucose and LDL lowering: the need for intensive therapy.

Del Prato S.

Curr Vasc Pharmacol. 2012 Nov;10(6):687-9. Review.

PMID:
23259554
9.

[Type 2 diabetes and cardiovascular risk: lessons from therapeutic trials].

Lièvre M.

Rev Prat. 2001 Oct 15;51(16):1793-9. French.

PMID:
11795124
10.

[Hypercholesterolemia as cardiovascular risk in hypertensive patients. Therapeutic implications: efficiency of statins].

Borghi C, Veronesi M.

Recenti Prog Med. 2003 Oct;94(10):421-6. Review. Italian.

PMID:
14619187
11.

Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians.

Vijan S, Hayward RA; American College of Physicians..

Ann Intern Med. 2004 Apr 20;140(8):650-8. Review.

PMID:
15096337
12.
13.
14.

The evolution of European guidelines: changing the management of cholesterol levels.

Erhardt LR, Gotto A Jr.

Atherosclerosis. 2006 Mar;185(1):12-20. Epub 2005 Nov 23. Review.

PMID:
16309687
15.

Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.

Wens J, Gerard R, Vandenberghe H.

Prim Care Diabetes. 2011 Apr;5(1):19-24. doi: 10.1016/j.pcd.2010.09.006. Epub 2010 Oct 27.

PMID:
21030327
16.

Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia.

Tai TS, Sheu WH, Lee WJ, Yao HT, Chiang MT.

Diabetes Care. 2000 Nov;23(11):1703-4. No abstract available.

PMID:
11092297
17.

The management of type 2 diabetes mellitus: a novel approach for addressing glycemic and lipid control with colesevelam HCl.

Wright WL.

Adv Nurse Pract. 2009 Nov;17(11):suppl 1-16. No abstract available.

PMID:
20014684
18.

Pre-existing cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: a matched cohort study.

Fu AZ, Qiu Y, Radican L, Yin DD, Mavros P.

Cardiovasc Diabetol. 2010 Apr 21;9:15. doi: 10.1186/1475-2840-9-15.

19.

The role of colesevelam hydrochloride in hypercholesterolemia and type 2 diabetes mellitus.

Brunetti L, Hermes-Desantis ER.

Ann Pharmacother. 2010 Jul-Aug;44(7-8):1196-206. doi: 10.1345/aph.1M728. Epub 2010 Jun 15. Review.

PMID:
20551301
20.

[Progress of berberine for treatment of type 2 diabetes].

Deng XW, Xie N.

Zhongguo Zhong Yao Za Zhi. 2014 Apr;39(8):1374-8. Review. Chinese.

PMID:
25039167

Supplemental Content

Support Center